- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 20, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by International Business Times referenced an article published in a supplement to The American Journal of Managed Care® (AJMC®), titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” In assessing the financial burden of Alzheimer disease, researchers said that unless new treatments or cures are developed, current treatment costs of $305 billion per year will rise to more than $1 trillion by 2050.
A piece by The Week spotlighted a video interview published on AJMC.com, the website of AJMC®. The interview, “Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine,” discussed false beliefs about COVID-19 vaccination, and why there is no good reason not to get inoculated, especially as the Delta variant spreads.
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More
